This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Wiskott-Aldrich Syndrome, Hematopoietic Stem Cell Transplantation or Graft Failure
and you are
between 1 and 19
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

Treatment Study to assess of safety and efficiency of conditioning with Plerixafor and G-CSF as additional agents for prevention of graft failure after transplantation with TCR alpha/beta grafts depletion in patient with Wiskott-Aldrich syndrome.

Provided treatments

  • Biological: G-CSF for Conditioning before HSCT.
  • Biological: Plerixafor for Conditioning before HSCT.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03019809. The sponsor of the trial is Federal Research Institute of Pediatric Hematology, Oncology and Immunology and it is looking for 30 volunteers for the current phase.
Official trial title:
A Trial of Plerixafor With G-CSF as Additional Agents in Conditioning Regimen for Prevention of Graft Failure After Transplantation With TCR Alpha/Beta Grafts Depletion in Patients With Wiskott-Aldrich Syndrome.